Finzati - Logo
AIMD logo

Ainos, Inc.

AIMD • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$6.38M
Growth
-24.5%
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$6.38M
52W Range1.26 - 4.50
Beta2.45
Gross Margin-37.67%
Oper. Margin-112.68%
Profit Margin-118.97%
Debt/Eq1.45
Current Ratio1.06
Quick Ratio0.78
Revenue 5Y-24.49%

Investment DNA

How strong this company looks for long-term investors

31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
38/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/8/2021
Industry: Biotechnology
P/B i: 0.93
Debt / Equity i: 1.45
Operating Margin: -11268.32%
Net Margin: -11897.04%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 1.45
Current Ratio: 1.06
Quick Ratio: 0.78
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 4 high-volume insider sells detected
chiang yao-chung
Transaction: 06/05/2026
BUY
Change
+3,500
Price
$2.05
Filing
06/09/2026
Type
BUY
chiang yao-chung
Transaction: 06/03/2026
BUY
Change
+2,000
Price
$2.13
Filing
06/05/2026
Type
BUY
chiang yao-chung
Transaction: 05/28/2026
BUY
Change
+250
Price
$2.30
Filing
06/01/2026
Type
BUY